Synthesis, structural characterization, in vitro biological activity, and DFT calculations of Cu(II) complex

Abstract

Using a diazonium combination of aniline and 1,3‐diphenylpropane‐1,3‐dione, the Japp‐Klingemann reaction yielded the 1,3‐diphenyl‐2‐(2‐phenylhydrazono)propane‐1,3‐dione ligand (HL). The copper (II) complex has been made using copper (II) acetate salt. The geometry of HL and its Cu (II) chelate were described through CHN analyses, FTIR, UV–Visible, XRD, TGA, and magnetic susceptibility tests. According to the spectral data, the ligand exhibits monobasic bidentate behavior by connecting through the N atom of hydrazone moiety (=N − NH−) by deprotonating beside the oxygen atom of the carbonyl (C=O) group forming octahedral geometry. Density functional theory (DFT) calculations were done by molecular studio software to examine the optimal geometry of HL and its complexity. MCF‐7 and HepG‐2 cell lines demonstrated anticancer action in response to the HL and its copper (II) complex. Additionally, inhibition zone diameter was used to assess the in vitro antibacterial action of HL and particular complex toward Gram +ve bacteria Staphylococcus aureus and Gram‐ve bacteria Escherichia coli (E. coli). Both viscosity and absorption spectra of Calf‐thymus DNA binding experimentations were used to examine the compounds.